Michel Boisseau
Overview
Explore the profile of Michel Boisseau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gil P, Exbrayat A, Loire E, Rakotoarivony I, Charriat F, Morel C, et al.
Virus Evol
. 2023 Sep;
9(2):vead054.
PMID: 37719779
Our knowledge of the diversity of eukaryotic viruses has recently undergone a massive expansion. This diversity could influence host physiology through yet unknown phenomena of potential interest to the fields...
2.
Courtot E, Boisseau M, Dhorne-Pollet S, Serreau D, Gesbert A, Reigner F, et al.
PeerJ
. 2023 Apr;
11:e15124.
PMID: 37070089
Basic knowledge on the biology and epidemiology of equine strongylid species still needs to be improved to contribute to the design of better parasite control strategies. Nemabiome metabarcoding is a...
3.
Boisseau M, Dhorne-Pollet S, Bars-Cortina D, Courtot E, Serreau D, Annonay G, et al.
iScience
. 2023 Feb;
26(2):106044.
PMID: 36818309
The nature and strength of interactions entertained among helminths and their host gut microbiota remain largely unexplored. Using 40 naturally infected Welsh ponies, we tracked the gut microbiota-cyathostomin temporal dynamics...
4.
Patterns of variation in equine strongyle community structure across age groups and gut compartments
Boisseau M, Mach N, Basiaga M, Kuzmina T, Laugier C, Salle G
Parasit Vectors
. 2023 Feb;
16(1):64.
PMID: 36765420
Background: Equine strongyles encompass more than 64 species of nematode worms that are responsible for growth retardation and the death of animals. The factors underpinning variation in the structure of...
5.
Malsa J, Courtot E, Boisseau M, Dumont B, Gombault P, Kuzmina T, et al.
Parasitology
. 2022 Aug;
149(11):1439-1449.
PMID: 35929352
Alternative strategies to chemical anthelmintics are needed for the sustainable control of equine strongylids. Bioactive forages like sainfoin () could contribute to reducing drug use, with the first hints of...
6.
Constant O, Gil P, Barthelemy J, Bollore K, Foulongne V, Desmetz C, et al.
Euro Surveill
. 2022 Jun;
27(25).
PMID: 35748300
BackgroundWest Nile virus (WNV) and Usutu virus (USUV), two closely related flaviviruses, mainly follow an enzootic cycle involving mosquitoes and birds, but also infect humans and other mammals. Since 2010,...
7.
Vazquez A, Sabourin E, Alda P, Leroy C, Leray C, Carron E, et al.
Transbound Emerg Dis
. 2020 Oct;
68(4):2274-2286.
PMID: 33068493
Fasciolosis is a worldwide spread parasitosis mainly caused by the trematode Fasciola hepatica. This disease is particularly important for public health in tropical regions, but it can also affect the...
8.
Gin H, Demeaux J, Grelaud A, Grolleau A, Droz-Perroteau C, Robinson P, et al.
Therapie
. 2013 Jul;
68(3):163-7.
PMID: 23886461
Objective: Estimate the effect of lifestyle adjustment activities in patients with metabolic syndrome treated by prescribed balneotherapy. Methods: Observational pilot cohort study with 12-month follow-up after multidimensional lifestyle training (physical,...
9.
Umar A, Depont F, Jacquet A, Lignot S, Segur M, Boisseau M, et al.
Thromb Res
. 2004 Nov;
115(1-2):31-7.
PMID: 15567450
Background: Cardiovascular mortality is especially low in southwest France (the French Paradox). In previous experimental studies, we found that alcohol-free extracts of armagnac could inhibit human platelet function in vitro...
10.
Umar A, Boisseau M, Yusup A, Upur H, Begaud B, Moore N
Fundam Clin Pharmacol
. 2004 Oct;
18(5):559-63.
PMID: 15482377
Recent in vitro studies, clinical trials and epidemiological studies have suggested possible interactions between aspirin and other cyclo-oxygenase (COX) inhibitors, such as ibuprofen of the COX-2 inhibitors celecoxib and rofecoxib....